Athena Countouriotis is the founder of Turning Point Therapeutics. Turning Point Therapeutics has raised $1.2B in total funding. Latest round: IPO.
Athena Countouriotis, M.D., is a physician and entrepreneur who co-founded Turning Point Therapeutics, a precision oncology company. She led the company through multiple financings, raising over $1.2 billion, before its acquisition by Bristol Myers Squibb for $4.1 billion. She later became CEO of Avenzo TX, another oncology startup.
Full founder directory · Investor directory · Company funding database · Fundraising library